EPS Creative Health Technology Group (HKSE:03860) Total Receivables: HK$52.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03860 EPS Creative Health Technology Group Ltd HKSE:03860
56 GF Score
Price HK$0.63
GF Value HK$0.59
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is EPS Creative Health Technology Group Total Receivables?

EPS Creative Health Technology Group HKSE:03860 +3.28% 56 Total Receivables is HK$52.1 Mil as of Mar. 2026. GuruFocus rates HKSE:03860 with a GF Score™ of 56/100 and a GF Value™ of HK$0.59 (Fairly Valued). The stock has 8 warning signs investors should review.

EPS Creative Health Technology Group's Total Receivables for the quarter that ended in Mar. 2026 was HK$52.1 Mil.

EPS Creative Health Technology Group Total Receivables Related Terms

EPS Creative Health Technology Group Total Receivables Historical Data

* Premium members only.

The historical data trend for EPS Creative Health Technology Group's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EPS Creative Health Technology Group Total Receivables Chart

EPS Creative Health Technology Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.59 59.27 71.64 73.78 52.14

EPS Creative Health Technology Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.64 133.44 73.78 94.63 52.14
HKSE:03860
56GF Score
EPS Creative Health Technology Group Ltd HKSE:03860
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EPS Creative Health Technology Group Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of HK$52.1 Mil mean?
EPS Creative Health Technology Group (HKSE:03860) has a Total Receivables of HK$52.1 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on EPS Creative Health Technology Group and its competitors.
Is EPS Creative Health Technology Group's Total Receivables too high?
EPS Creative Health Technology Group's current Total Receivables is HK$52.1 Mil. Overall, EPS Creative Health Technology Group has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EPS Creative Health Technology Group's Total Receivables compare to TJX and ROST?
EPS Creative Health Technology Group's Total Receivables of HK$52.1 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Retail - Cyclical company?
A good Total Receivables depends on the Retail - Cyclical industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on EPS Creative Health Technology Group and its competitors. EPS Creative Health Technology Group's current Total Receivables is HK$52.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Creative Health Technology Group stock overvalued right now?
Based on GuruFocus' analysis, EPS Creative Health Technology Group (HKSE:03860) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.59, compared to a current price of HK$0.63 — trading 6.8% above its estimated fair value. The current Total Receivables is HK$52.1 Mil. EPS Creative Health Technology Group's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For EPS Creative Health Technology Group (HKSE:03860), the current Total Receivables is HK$52.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EPS Creative Health Technology Group (HKSE:03860) Overvalued in 2026?

Based on GuruFocus' analysis, EPS Creative Health Technology Group stock appears to be overvalued. The current stock price of HK$0.63 is trading 6.8% above its estimated GF Value™ of HK$0.59. GuruFocus considers EPS Creative Health Technology Group to be Fairly Valued.

Key valuation signals for HKSE:03860:

  • Total Receivables: HK$52.1 Mil
  • GF Value™: HK$0.59 vs. price of HK$0.63 (6.8% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the HKSE:03860 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EPS Creative Health Technology Group Business Description

Address 23 Man Lok Street, Flat A, 17th Floor, Grandview Tower, Hung Hom, Kowloon, Hong Kong, HKG
EPS Creative Health Technology Group Ltd is an investment holding company. Its segment includes the Garment business, Healthcare Products Business, and IRO with CRO and In-House R&D Business. It generates maximum revenue from the Garment segment which includes the provision of apparel supply chain management services for knitwear apparel products. Geographically, it derives a majority of revenue from Japan and also has its presence in Hong Kong, Mainland China, Europe, United States and Other Countries.
56GF Score

Get the complete analysis for HKSE:03860

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.63
Price
HK$0.59
GF Value